alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 32.1**

 

**CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report ofBrooktrout, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31,2005 as filed with the Securities and Exchange Commission on the date hereof(the “Report”), I, Eric R. Giler, President of the Company, certify, pursuantto 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that:

 

(1)            The Report fully complies with therequirements of Section 13(a) or 15(d), as applicable, of the SecuritiesExchange Act of 1934; and

 

(2)            The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

 
| Date:    | May 10, 2005 | By:      | /s/ ERIC R. GILER                |
|----------|--------------|----------|----------------------------------|
|     |         |     | Eric R. Giler                    |
| * * | * *     | * * | *President*                      |
| * * | * *     | * * | *(Principal  Executive Officer)* |

 

----
Donald ECHOLS, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-4535

District Court of Appeal of Florida, Second District.

Opinion filed November 22, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2475 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2475

   To extend the temporary suspension of duty on Mixtures of N'-(3,4-
         dichloro-phenyl)-N,Ndimethylurea with acrylate rubber.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

 Mr. Brown of Ohio introduced the following bill; which was read twice 
                and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
   To extend the temporary suspension of duty on Mixtures of N'-(3,4-
         dichloro-phenyl)-N,Ndimethylurea with acrylate rubber.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF N'-(3,4-DICHLORO-PHENYL)-N,NDIMETHYLUREA WITH 
              ACRYLATE RUBBER.

    (a) In General.--Heading 9902.12.75 of the Harmonized Tariff 
Schedule of the United States (relating to Mixtures of N'-(3,4-
dichloro-phenyl)-N,Ndimethylurea with acrylate rubber) is amended by 
striking the date in the effective period column and inserting ``12/31/
2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Chestel R. THORSON, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-508

District Court of Appeal of Florida, Second District.

Opinion filed December 27, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 31.1
 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
      a.
    
    Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the
period in which this report is being prepared;b.
    
    Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles;c.
    
    Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report
based on such evaluation; andd.
    
    Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth
fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect,
the registrants internal control over financial reporting; and
  a.
    
    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; andb.
    
    Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants
internal control over financial reporting.
 Date: June 7, 2010
    /s/ Robert A. VirtueRobert A. VirtuePresident and Chief Executive Officer of Virco
Mfg. Corporation
(Principal Executive Officer)
v237484_ex10-11 -- Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing
Christopher Lee NICHOLS, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-1030

District Court of Appeal of Florida, Second District.

Opinion filed November 15, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
# Official Journal L 49/2014

| | ISSN 1977-0677
  doi:10.3000/19770677.L_2014.049.eng |
| --- | --- |
| Official Journal
  of the European Union | L 49 |
| | |
| English edition | Legislation | Volume 5719 February 2014 |

ISSN 1977-0677

doi:10.3000/19770677.L_2014.049.eng

Official Journal

of the European Union

L 49

English edition

Legislation

Volume 5719 February 2014

---

| Contents | | I   Legislative acts | page |
| --- | --- | --- | --- |
| | | BUDGETS |
| | | 2014/64/EU, Euratom |
| | * | Definitive adoption of Amending budget No 7 of the European Union for the financial year 2013 | 1 |
| | | 2014/65/EU, Euratom |
| | * | Definitive adoption of Amending budget No 8 of the European Union for the financial year 2013 | 13 |
| | | 2014/66/EU, Euratom |
| | * | Definitive adoption of Amending budget No 9 of the European Union for the financial year 2013 | 231 |

Contents

I   Legislative acts

page

BUDGETS

2014/64/EU, Euratom

*

Definitive adoption of Amending budget No 7 of the European Union for the financial year 2013

1

2014/65/EU, Euratom

*

Definitive adoption of Amending budget No 8 of the European Union for the financial year 2013

13

2014/66/EU, Euratom

*

Definitive adoption of Amending budget No 9 of the European Union for the financial year 2013

231

All amounts in this budget document are expressed in euro unless otherwise indicated.Any revenue provided for in Article 18(1) of the Financial Regulation, entered in Titles 5 and 6 of the statement of revenue, may lead to additional appropriations being entered on the headings which bore the initial expenditure giving rise to the corresponding revenue.Figures for outturn refer to all authorised appropriations, including budget appropriations, additional appropriations and earmarked revenue.A revised Financial Regulation entered into force on 27 October 2012 (Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002, OJ L 298, 26.10.2012, p. 1). In accordance with Article 212 of Regulation (EU, Euratom) No 966/2012, certain articles of Regulation (EC, Euratom) No 1605/2002 continue to apply until 31 December 2013.In the 2013 budget, all references to the Financial Regulation are based on Regulation (EU, Euratom) No 966/2012, with the exception of those articles of Regulation (EC, Euratom) No 1605/2002 which continue to apply until 31 December 2013.

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Order entered January 6, 2023

In the

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-20-00995-CR

No. 05-20-00996-CR

No. 05-20-00997-CR

No. 05-20-00998-CR

No. 05-20-01009-CR

No. 05-20-01010-CR

No. 05-20-01011-CR

No. 05-20-01014-CR

No. 05-20-01015-CR

No. 05-20-01016-CR

No. 05-20-01026-CR

No. 05-20-01027-CR

No. 05-20-01028-CR

No. 05-20-01029-CR

No. 05-20-01030-CR

No. 05-20-01031-CR

Bobby Carl Jessie, Appellant

V.

The State of Texas, Appellee

On Appeal from the 194th Judicial District Court

Dallas County, Texas

Trial Court Cause No. F-2020660-M

ORDER
The State’s Second Motion for Extension of Time to File Brief is 

GRANTED, and its brief, received on January 5, 2023, is ORDERED filed as of 

the date of this order.

/s/ CORY L. CARLYLE

JUSTICE
**EXHIBIT 32.2**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report ofBrooktrout, Inc. (the “Company”) on Form 10-Q for the quarter endedSeptember 30, 2004 as filed with the Securities and Exchange Commission on thedate hereof (the “Report”), I, Robert C. Leahy, Vice President of Finance andOperations of the Company, certify, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements ofSection 13(a) or 15(d), as applicable, of the Securities Exchange Act of1934, as amended; and

 

(2) The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 
| Date: November 9, 2004 | By:    | /s/  ROBERT  C. LEAHY                                                                               |
|------------------------|--------|---------------------------------------------------------------------------------------------------------------|
|                   |   | Robert C. Leahy

*Vice  President of Finance and Operations*

*(Principal  Financial and Accounting Officer)* |

 

----
Flight Log
Flight Log
# Official Journal C 161/2021

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 161 |
| | |
| English edition | Information and Notices | Volume 643 May 2021 |

ISSN 1977-091X

Official Journal

of the European Union

C 161

English edition

Information and Notices

Volume 643 May 2021

---

| Contents | page |
| --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2021/C 161/01 | Euro exchange rates — 30 April 2021 | 1 |

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2021/C 161/01

Euro exchange rates — 30 April 2021

1

---

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMMON COMMERCIAL POLICY |
| | European Commission |
| 2021/C 161/02 | Notice of the impending expiry of certain anti-dumping measures | 2 |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2021/C 161/03 | Prior notification of a concentration (Case M.10248 – AP/Lutech) – Candidate case for simplified procedure (
  1
  ) | 3 |
| 2021/C 161/04 | Prior notification of a concentration (Case M.10196 — Magna/LGE/JV) – Candidate case for simplified procedure (
  1
  ) | 5 |
| | OTHER ACTS |
| | European Commission |
| 2021/C 161/05 | Publication of a communication of approval of a standard amendment to a product specification for a name in the wine sector referred to in Article 17(2) and (3) of Commission Delegated Regulation (EU) 2019/33 | 7 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMMON COMMERCIAL POLICY

European Commission

2021/C 161/02

Notice of the impending expiry of certain anti-dumping measures

2

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2021/C 161/03

Prior notification of a concentration (Case M.10248 – AP/Lutech) – Candidate case for simplified procedure (
  1
  )

1

3

2021/C 161/04

Prior notification of a concentration (Case M.10196 — Magna/LGE/JV) – Candidate case for simplified procedure (
  1
  )

1

5

OTHER ACTS

European Commission

2021/C 161/05

Publication of a communication of approval of a standard amendment to a product specification for a name in the wine sector referred to in Article 17(2) and (3) of Commission Delegated Regulation (EU) 2019/33

7

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
Exhibit 32.0

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of BV Financial, Inc. (the Company) on Form 10-K for the
fiscal year ended June 30, 2008, as filed with the Securities and Exchange Commission (the Report), I hereby certify pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in this Report fairly presents, in all material respects, the consolidated financial condition and results of the Company as of and for the period covered
by this Report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



By:

/s/ Carolyn M. MrozCarolyn M. Mroz President and Chief Executive OfficerSeptember 23, 2008By:

/s/ Edmund T. LeonardEdmund T. LeonardChairman of the Board and Chief Financial OfficerSeptember 23, 2008
Exhibit 10.06


Exhibit 10.06
II 

118TH CONGRESS 

1ST SESSION S. 1373 

To increase access to medication for opioid overdose reversal, and for other 

purposes. 

IN THE SENATE OF THE UNITED STATES 

APRIL 27, 2023 

Mr. MARKEY (for himself, Mr. BOOKER, Mr. MARSHALL, and Mr. BRAUN) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To increase access to medication for opioid overdose reversal, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Naloxone Affordability 

5 Act of 2023’’. 

6 SEC. 2. GAO STUDY ON NALOXONE ACCESS. 

7 (a) IN GENERAL.—Not later than 1 year after the 

8 date of the enactment of this Act, the Comptroller General 

9 of the United States shall conduct a study on actions that 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•S 1373 IS

1 may be taken to protect access to naloxone for individuals 

2 seeking to purchase naloxone. Such study shall address— 

3 (1) coverage of naloxone (in any available form) 

4 as an over-the-counter product— 

5 (A) under a group health plan or group or 

6 individual health insurance coverage (as such 

7 terms are defined in section 2791 of the Public 

8 Health Service Act (42 U.S.C. 300gg–91)); and 

9 (B) for individuals entitled to benefits 

10 under part A or enrolled under part B of title 

11 XVIII of the Social Security Act (42 U.S.C. 

12 1395 et seq.) or receiving medical assistance 

13 under a State plan under title XIX of such Act 

14 (42 U.S.C. 1396 et seq.) (or a waiver of such 

15 plan); and 

16 (2) the out-of-pocket cost to consumers pur17 chasing naloxone under any such plan or coverage. 

18 (b) REPORT.—Not later than 1 year after the date 

19 of the enactment of this Act, the Comptroller General of 

20 the United States shall submit to Congress a report that 

21 contains the findings of the study conducted under sub22 section (a). 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2537 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2537

     To suspend temporarily the duty on formaldehyde, polymer with 
   methylphenol, 2-hydroxy-3-[(1-oxo-2-propenyl)oxy]propyl ether and 
 formaldehyde, polymer with (chloromethyl)oxirane and methylphenol, 4-
              cyclohexene-1,2-dicarboxylate 2-propenoate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Reid introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
     To suspend temporarily the duty on formaldehyde, polymer with 
   methylphenol, 2-hydroxy-3-[(1-oxo-2-propenyl)oxy]propyl ether and 
 formaldehyde, polymer with (chloromethyl)oxirane and methylphenol, 4-
              cyclohexene-1,2-dicarboxylate 2-propenoate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FORMALDEHYDE, POLYMER WITH METHYLPHENOL, 2-HYDROXY-3-[(1-
              OXO-2-PROPENYL)OXY]PROPYL ETHER AND FORMALDEHYDE, POLYMER 
              WITH (CHLOROMETHYL)OXIRANE AND METHYLPHENOL, 4-
              CYCLOHEXENE-1,2-DICARBOXYLATE 2-PROPENOATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Formaldehyde,       Free         No change        No change        On or before 12/  ''.
                        polymer with                                                       31/2015.......
                        methylphenol, 2-
                        hydroxy-3-[(1-oxo-
                        2-
                        propenyl)oxy]prop
                        yl ether (CAS No.
                        126901-56-2); and
                        formaldehyde,
                        polymer with
                        (chloromethyl)oxi
                        rane and
                        methylphenol, 4-
                        cyclohexene-1,2-
                        dicarboxylate 2-
                        propenoate (CAS
                        No. 182697-62-7)
                        (provided for in
                        subheading
                        3907.30.00)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
<PAGE>

                                                                    EXHIBIT 32.1


      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
           PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



    This Certificate is being delivered pursuant to the requirements of
Section 1350 of Chapter 63 (Mail Fraud) of Title 18 (Crimes and Criminal
Procedures) of the United States Code and shall not be relied on by any person
for any other purpose.

    The undersigned, who are the Chief Executive Officer and Chief
Financial Officer, respectively, of Education Realty Trust, Inc. (the
"Company"), hereby each certify that, to the undersigned's knowledge:

    The Annual Report on Form 10-K of the Company for the period July 12, 2004
through December 31, 2004 (the "Report"), which accompanies this Certification,
fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and all information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company.

    Dated this 31st day of March, 2005.


                                    /s/ Paul O. Bower
                                    -----------------------------------------
                                    Paul O. Bower, Chief Executive Officer


                                    /s/ Randall H. Brown
                                    -----------------------------------------
                                    Randall H. Brown, Chief Financial Officer



    In accordance with SEC Release No. 34-47986, this Exhibit is furnished
to the SEC as an accompanying document and is not deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that Section, nor shall it be deemed incorporated by reference
into any filing under the Securities Act of 1933. A signed original of this
written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has
been provided to the registrant and will be retained by the registrant and
furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE>                      5
<CIK>                          0000751255
<NAME>                         DYCO OIL & GAS PROGRAM 1985-1 LIMITED PARTNERSHIP
                                
<S>                            <C>
<PERIOD-TYPE>                  6-MOS
<FISCAL-YEAR-END>              DEC-31-1998
<PERIOD-START>                 JAN-01-1998
<PERIOD-END>                   JUN-30-1998
<CASH>                             64,246
<SECURITIES>                            0
<RECEIVABLES>                      47,939
<ALLOWANCES>                            0
<INVENTORY>                             0
<CURRENT-ASSETS>                  112,185
<PP&E>                         20,980,422
<DEPRECIATION>                 20,855,012
<TOTAL-ASSETS>                    252,029
<CURRENT-LIABILITIES>              19,729
<BONDS>                                 0
<PREFERRED-MANDATORY>                   0
<PREFERRED>                             0
<COMMON>                                0
<OTHER-SE>                        208,345
<TOTAL-LIABILITY-AND-EQUITY>      252,029
<SALES>                           169,022
<TOTAL-REVENUES>                  170,143
<CGS>                                   0
<TOTAL-COSTS>                      98,326
<OTHER-EXPENSES>                        0
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                      0
<INCOME-PRETAX>                    71,817
<INCOME-TAX>                            0
<INCOME-CONTINUING>                71,817
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                       71,817
<EPS-PRIMARY>                       17.34
<EPS-DILUTED>                           0
        
 

</TABLE>